Larvol Delta - Acumen-Pharmaceuticals-to-Present-Clinical-Trial-Design-for-INTERCEPTAD-the-Phase-1-PlaceboControlled-Single-and-MultipleDose-Clinical-Trial-of-ACU193-at-2021-Clinical-Trials-on-Alzheimers-Disease-CTAD-Conference

ACU193 - Acumen Pharma

https://www.globenewswire.com/news-release/2021/11/02/2325333/0/en/Acumen-Pharmaceuticals-to-Present-Clinical-Trial-Design-for-INTERCEPT-AD-the-Phase-1-Placebo-Controlled-Single-and-Multiple-Dose-Clinical-Trial-of-ACU193-at-2021-Clinical-Trials-on.html

Nov 2, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next